Adherence to zidovudine (AZT) among HIV-infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care

Drug and Alcohol Dependence

Volumn 37, Issue 3, 1995, Pages 261-269

  Wall, Tamara L ^a   Sorensen, James L ^a   Batki, Steven L ^a   Delucchi, Kevin L ^a   London, Julie A ^a   Chesney, Margaret A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adherence; Compliance; Human immunodeficiency virus (HIV); Methadone; Supervised therapy; Zidovudine (AZT)

Indexed keywords

METHADONE; ZIDOVUDINE;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DEPENDENCE; ERYTHROCYTE; FEMALE; FOLLOW UP; HEALTH CENTER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEAN CORPUSCULAR VOLUME; MEDICAL RESEARCH; METHADONE TREATMENT; ORAL DRUG ADMINISTRATION; PATIENT CARE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT;

ADULT; CD4 LYMPHOCYTE COUNT; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HUMANS; MALE; METHADONE; MIDDLE AGED; NURSE-PATIENT RELATIONS; PATIENT CARE TEAM; PATIENT EDUCATION; PILOT PROJECTS; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT REFUSAL; ZIDOVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0028939631     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/0376-8716(94)01080-5     Document Type: Article

References (43)

1. Update: acquired immunodeficiency syndrome associated with intravenous drug use — United States, 1988
2. Projections of the number of persons with AIDS and the number of immunosuppressed HIV-infected persons — United States, 1992–1994
3. Tuberculosis prevention in drug treatment centers and correctional facilities — selected US sites, 1990–1991
4. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
5. A pilot study of lowdose zidovudine in human immunodeficiency virus (HIV) infection
6. Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter
7. How often is medication taken as prescribed? A novel assessment technique
8. Construct validity comparisons of three methods for measuring patient compliance
9. Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease
10. Adherence in the safety and efficacy study of zidovudine in the treatment of subjects with mildly symptomatic HIV
11. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex
12. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type I (HIV) infection: a double-blind placebo-controlled trial
13. Diagnosis and management of non-compliance
14. Medical care of HIV disease in methadone maintenance treatment
15. Simultaneous quantification of zidovudine and its glucoronide in serum high-performance liquid chromatography
16. The inaccuracy of using interviews to estimate patient reliability of taking medications at home
17. Prevalence of HIV infection among intravenous drug users in the United States
18. A critical review of the ‘determinants’ of patient compliance with therapeutic regimens
19. The health belief model: a decade later
20. The use of nitrogen mustard in the palliative treatment of carcinoma
21. Effects of zidovudine therapy in minority and other sub-populations with early HIV infection
22. Pharmacists' interventions using an electronic medication-event monitoring devices adherence data versus pill counts
23. Successful supervised ambulatory management of tuberculosis treatment failures
24. Zidovudine and the natural history of the acquired immunodeficiency syndrome
25. Determinants of subject compliance within an experimental anti-HIV drug protocol
26. Red cell size and age
27. Smoking and blood changes
28. Assessment and its impact on adherence
29. Compliance with zidovudine therapy
30. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex
31. In search of the gold standard for compliance measurement
32. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type I: a cross-sectional study in a municipal hospital clinic
33. Antiretroviral therapy for adult HIV-infected patients Recommendations from a state-of-the-art conference
34. Cost effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection
35. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection
36. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection
37. Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program
38. Differences in access to zidovudine among symptomatic HIV-infected persons
39. A nebulizer chronolog to monitor compliance with inhaler use
40. Providing medical care to methadone clinic patients: referral versus on-site care
41. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter
42. Adherence to zidovudine (AZT) in HIV-infected injection drug users
43. Macrocytosis of chronic alcoholism